Located in San Francisco, Calif., FibroGen Inc. is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. It discovers, develops and commercializes novel therapeutics for serious unmet medical needs. The company's major investors include Adage Capital Management, Brookside Capital Partners, Corriente...